80 related articles for article (PubMed ID: 15664071)
1. Assessment of human papillomavirus mRNA detection over time in cervical specimens collected in liquid based cytology medium.
Cuschieri KS; Beattie G; Hassan S; Robertson K; Cubie H
J Virol Methods; 2005 Mar; 124(1-2):211-5. PubMed ID: 15664071
[TBL] [Abstract][Full Text] [Related]
2. Analytical performance of RNA isolated from BD SurePath™ cervical cytology specimens by the PreTect™ HPV-Proofer assay.
Dixon EP; Grønn P; King LM; Passineau H; Doobay H; Skomedal H; Hariri J; Hay SN; Brown CA; Fischer TJ; Malinowski DP
J Virol Methods; 2012 Nov; 185(2):199-203. PubMed ID: 22820075
[TBL] [Abstract][Full Text] [Related]
3. Isolation of RNA from residual BD SurePath liquid-based cytology specimens and detection of HPV E6/E7 mRNA using the PreTectt HPV-Proofer assay.
Dixon EP; King LM; Adams MD; Grønn P; Murphy PG; Brown CA; Brough GH; Skomedal H; Malinowski DP; Fischer TJ
J Virol Methods; 2008 Dec; 154(1-2):220-2. PubMed ID: 18761379
[TBL] [Abstract][Full Text] [Related]
4. Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets.
Getman D; Aiyer A; Dockter J; Giachetti C; Zhang F; Ginocchio CC
J Clin Virol; 2009 Jul; 45 Suppl 1():S49-54. PubMed ID: 19651369
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus E6/E7 mRNA expression in women younger than 30 years of age.
Molden T; Kraus I; Karlsen F; Skomedal H; Hagmar B
Gynecol Oncol; 2006 Jan; 100(1):95-100. PubMed ID: 16153696
[TBL] [Abstract][Full Text] [Related]
6. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses.
Molden T; Kraus I; Skomedal H; Nordstrøm T; Karlsen F
J Virol Methods; 2007 Jun; 142(1-2):204-12. PubMed ID: 17379322
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring.
Cuschieri KS; Whitley MJ; Cubie HA
J Med Virol; 2004 May; 73(1):65-70. PubMed ID: 15042650
[TBL] [Abstract][Full Text] [Related]
8. NucliSENS EasyQ HPV v1 test - Testing for oncogenic activity of human papillomaviruses.
Jeantet D; Schwarzmann F; Tromp J; Melchers WJ; van der Wurff AA; Oosterlaken T; Jacobs M; Troesch A
J Clin Virol; 2009 Jul; 45 Suppl 1():S29-37. PubMed ID: 19651366
[TBL] [Abstract][Full Text] [Related]
9. Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi.
Depuydt CE; Benoy IH; Bailleul EJ; Vandepitte J; Vereecken AJ; Bogers JJ
Cytopathology; 2006 Dec; 17(6):374-81. PubMed ID: 17168921
[TBL] [Abstract][Full Text] [Related]
10. Isolation of RNA from cell lines and cervical cytology specimens stored in BD SurePath preservative fluid and downstream detection of housekeeping gene and HPV E6 expression using real time RT-PCR.
Murphy PG; Henderson DT; Adams MD; Horlick EA; Dixon EP; King LM; Avissar PL; Brown CA; Fischer TJ; Malinowski DP
J Virol Methods; 2009 Mar; 156(1-2):138-44. PubMed ID: 19095009
[TBL] [Abstract][Full Text] [Related]
11. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of human papillomavirus genotyping in cervical liquid-based cytology specimens; using the Roche Linear Array HPV genotyping assay.
Jamison J; Wilson RT; Carson J
Cytopathology; 2009 Aug; 20(4):242-8. PubMed ID: 19291176
[TBL] [Abstract][Full Text] [Related]
13. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
14. Stability of PreservCyt for Hybrid Capture (HC II) HPV test.
Sailors J; Gander R; Saboorian MH; Berkley P; Foster B; Ashfaq R
Diagn Cytopathol; 2005 May; 32(5):260-3. PubMed ID: 15830373
[TBL] [Abstract][Full Text] [Related]
15. Detection and genotyping analysis of human papillomavirus isolates from liquid-based cervical cytology specimens.
Avissar P; Malinowski DP
Methods Mol Biol; 2009; 511():361-70. PubMed ID: 19347306
[TBL] [Abstract][Full Text] [Related]
16. Recovery of DNA from BD SurePath cytology specimens and compatibility with the Roche AMPLICOR Human Papillomavirus (HPV) Test.
Dixon EP; Lenz KL; Doobay H; Brown CA; Malinowski DP; Fischer TJ
J Clin Virol; 2010 May; 48(1):31-5. PubMed ID: 20233675
[TBL] [Abstract][Full Text] [Related]
17. High-throughput cervical cancer screening using intracellular human papillomavirus E6 and E7 mRNA quantification by flow cytometry.
Narimatsu R; Patterson BK
Am J Clin Pathol; 2005 May; 123(5):716-23. PubMed ID: 15981811
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of HPV 16 PCR detection in self- compared with clinician-collected samples in women referred for colposcopy.
Daponte A; Pournaras S; Mademtzis I; Hadjichristodoulou C; Kostopoulou E; Maniatis AN; Messinis IE
Gynecol Oncol; 2006 Nov; 103(2):463-6. PubMed ID: 16626791
[TBL] [Abstract][Full Text] [Related]
19. [Detection of high-risk human papillomavirus (HPV) E6 and E7 oncogene transcripts increases the specificity of the detection of a cervical intraepithelial neoplasia (CIN)].
Sotlar K; Diemer D; Stubner A; Menton S; Menton M; Dietz K; Wallwiener D; Bültmann B
Verh Dtsch Ges Pathol; 2005; 89():195-200. PubMed ID: 18035691
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma.
Lie AK; Kristensen G
Expert Rev Mol Diagn; 2008 Jul; 8(4):405-15. PubMed ID: 18598223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
